Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Capital Expenditures (2016 - 2022)

Palisade Bio (PALI) has disclosed Capital Expenditures for 10 consecutive years, with $10000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Capital Expenditures changed N/A to $10000.0 in Q4 2022 year-over-year; TTM through Sep 2024 was $10000.0, a 9.09% decrease, with the full-year FY2023 number at $4000.0, down 60.0% from a year prior.
  • Capital Expenditures was $10000.0 for Q4 2022 at Palisade Bio, up from $1000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $10000.0 in Q4 2022 to a low of -$1000.0 in Q3 2020.